HTS promiscuity analyses for accelerating decision making

Journal of Biomolecular Screening

Volumn 16, Issue 7, 2011, Pages 765-774

  Böcker, Alexander ^a   Bonneau, Pierre R ^b   Edwards, Paul J ^b  

^a EVOTEC AG   (Germany)

^b BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

chemoinformatics; compound repositories; frequent hitters; high throughput screening; promiscuity

Indexed keywords

ARTICLE; DATA BASE; DECISION MAKING; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL;

DATABASES, FACTUAL; DECISION MAKING; HIGH-THROUGHPUT SCREENING ASSAYS; MODELS, STATISTICAL; PHOSPHOTRANSFERASES; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960897912     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111407763     Document Type: Article

References (16)

1. Rishton G. M.. Nonleadlikeness and Leadlikeness in Biochemical Screening. Drug Discov. Today. 2003 ; 8: 86-96 (Pubitemid 36139902)
2. Rishton G. M.. Reactive Compounds and In Vitro False-Positives in HTS. Drug Discov. Today. 1997 ; 2: 382-384 (Pubitemid 27368216)
3. Hann M. M., Leach A. R., Harper G.. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery. J. Chem. Inf. Comput. Sci.. 2001 ; 41: 856-864
4. Roche O., Schneider P., Zuegge J., Gua W., Kansy M., Alanine A., Bleicher K., Danel F., Gutknecht E. V., Rogers-Evans M., et al. Development of a Virtual Screening Method for Identification of "Frequent Hitters" in Compound Libraries. J. Med. Chem.. 2002 ; 45: 137-142 (Pubitemid 34038548)
5. Pearce B. C., Sofia M. J., Good A. C., Drexler D. M., Stock D. A.. An Empirical Process for the Design of High-Throughput Screening Deck Filters. J. Chem. Inf. Model.. 2006 ; 46: 1060-1068 (Pubitemid 43999150)
6. Coan K. E. D., Maltby D. A., Burlingame A. L., Shoichet B. K.. Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding. J. Med. Chem.. 2009 ; 52: 2067-2075
7. Rousseeuw P. J., Croux C.. Alternatives to the Median Absolute Deviation. J. Am. Stat. Assoc.. 1993 ; 88: 1273-1283
8. Walters W. P., Namchuk M.. Designing Screens: How to Make Your Hits a Hit. Nat. Rev. Drug Discov.. 2003 ; 2: 259-266 (Pubitemid 37361684)
9. Hertzberg R. P., Pope A. J.. High-Throughput Screening: New Technology for the 21st Century. Curr. Opin. Chem. Biol.. 2000 ; 4: 445-451 (Pubitemid 30621048)
10. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J.. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Del. Rev.. 1997 ; 23: 3-25 (Pubitemid 27046991)
11. Veber D. F., Johnson S. R., Cheng H. Y., Smith B. R., Ward K. W., Kopple K. D.. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem.. 2002 ; 45: 2615-2623 (Pubitemid 34595232)
12. Böcker A.. Toward an Improved Clustering of Large Data Sets Using Maximum Common Substructures and Topological Fingerprints. J. Chem. Inf. Model.. 2008 ; 48: 2097-2107
13. Chohan K. K., Paine S. W., Mistry J., Barton P., Davis A. M.. A Rapid Computational Filter for Cytochrome P450 1A2 Inhibition Potential of Compound Libraries. J. Med. Chem.. 2005 ; 48: 5154-5161 (Pubitemid 41113903)
14. Hsu J. C. Multiple Comparisons: Theory and Methods. London: Chapman & Hall ; 1996 :
15. Overington J. P., Al-Lazikani B., Hopkins A. L.. How Many Drug Targets Are There?. Nat. Rev. Drug Discov.. 2006 ; 5: 993-996 (Pubitemid 44835126)
16. Hitchcock S. A., Pennington L. D.. Structure-Brain Exposure Relationships. J. Med. Chem.. 2006 ; 49: 7559-7583 (Pubitemid 46033646)